Gyeonggi-do, South Korea

Young Joo Choi

This inventor holds 1 USPTO granted patent. Top assignee: Gi Cell, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Young Joo Choi. Retrieved from https://idiyas.com/inventor/young-joo-choi-509mn88o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Young Joo Choi: Innovator in T Cell Culture Technology

Introduction

Young Joo Choi is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of cellular biology, particularly in the area of T cell culture. His innovative work has led to the development of a unique medium composition that enhances the culturing of T cells.

Latest Patents

Young Joo Choi holds a patent for a "Medium Composition for Culturing T Cells and Method for Culturing T Cells Using Same." This patent represents a breakthrough in the methods used to culture T cells, which are crucial for various therapeutic applications.

Career Highlights

Choi is currently associated with Gi Cell, Inc., where he continues to advance research in cellular technologies. His work has been instrumental in improving the efficiency and effectiveness of T cell cultures, which are vital for immunotherapy and other medical treatments.

Collaborations

He collaborates with notable colleagues, including Chun-Pyo Hong and June Sub Lee, who contribute to the research and development efforts at Gi Cell, Inc. Their combined expertise fosters an environment of innovation and progress in the field.

Conclusion

Young Joo Choi's contributions to T cell culture technology exemplify the impact of innovative thinking in the life sciences. His patent and ongoing work at Gi Cell, Inc. highlight the importance of advancements in cellular research for future medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…